RedHill Biopharma Terminates License Agreement for Aemcolo®

TEL-AVIV, Israel and RALEIGH, NC, July 9, 2024 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced the mutual decision with Cosmo Technologies Ltd. (“Cosmo”) to voluntary terminate their exclusive U.S….

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks